e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Chest physiotherapy and breathing retraining
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nebulised 7% hypertonic saline improves health related quality of life in patients with non-cystic fibrosis bronchiectasis
R. Johnston, F. Shaw, R. Wilson, M. Loebinger, L. Flude (London, United Kingdom)
Source:
Annual Congress 2011 - Chest physiotherapy and breathing retraining
Session:
Chest physiotherapy and breathing retraining
Session type:
Oral Presentation
Number:
2978
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Johnston, F. Shaw, R. Wilson, M. Loebinger, L. Flude (London, United Kingdom). Nebulised 7% hypertonic saline improves health related quality of life in patients with non-cystic fibrosis bronchiectasis. Eur Respir J 2011; 38: Suppl. 55, 2978
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Berndt Roman - 27.11.2011 01:35
Thank you for the presentation and please do not forget to send me a pdf :-) Roman
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Home versus hospital treatment of acute cystic fibrosis pulmonary exacerbations – Is quality of life really better at home?
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010
Frequent outpatient exacerbations of non cystic fibrosis bronchiectasis leads to impaired health related quality of life
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Impact of bronchiectasis and trapped air on quality of life and exacerbations in cystic fibrosis
Source: Eur Respir J 2013; 42: 371-379
Year: 2013
Effect of short-term inhalation of warm saline atomised gas on patients with non-cystic fibrosis bronchiectasis
Source: ERJ Open Res, 6 (1) 00130-2019; 10.1183/23120541.00130-2019
Year: 2020
Nebulized saline treatment in patients with concomitant asthma and bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)
Source: Eur Respir J 2010; 35: 118-123
Year: 2010
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
Source: Eur Respir J 2002; 19: 209-216
Year: 2002
Increase in health status after 12 days treatment with inhaled mannitol in patients with bronchiectasis
Source: Eur Respir J 2003; 22: Suppl. 45, 430s
Year: 2003
RCT Abstract - The effect of inhaled hypertonic saline on lung structure in preschool children with cystic fibrosis
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
The efficacy and tolerability of inhaled hypertonic saline in children with cystic fibrosis
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020
The use of home intravenous antibiotics in adult non-CF bronchiectasis
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015
Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings
Year: 2013
Health-related quality of life in non-cystic fibrosis bronchiectasis children
Source: Annual Congress 2011 - Rare lung diseases in children
Year: 2011
Hospital admissions are linked to a poor health related quality of life in patients with non cystic fibrosis bronchiectasis
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007
Safety and efficacy of 7% hypertonic saline in patients with bronchiectasis
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Nebulised colistimethate sodium improves quality of life in patients with bronchiectasis colonised by
pseudomonas aeruginosa
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Patients’ expectations and quality of life before introduction of pirfenidone used in idiopathic pulmonary fibrosis.
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018
Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept